Flawless Labs, Inc. d/b/a Flawless Vape Shop

Warning LetterOpen

Jason Grace Flawless Labs, Inc. d/b/a Flawless Vape Shop 17612 Fm 969, Suite J Manor , TX 78653 United States info@flawlessvapeshop.com flawlessvapeshop@gmail.com jason@flawlessvapedistro.comFEI 3014131781Issued Aug 27, 2021Center for Tobacco Products

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3014131781.

Violations1

Issue DateAug 27, 2021

Product TypeTobacco

StatusOpen

Letter Details

Firm: Flawless Labs, Inc. d/b/a Flawless Vape Shop
Location: Jason Grace Flawless Labs, Inc. d/b/a Flawless Vape Shop 17612 Fm 969, Suite J Manor , TX 78653 United States info@flawlessvapeshop.com flawlessvapeshop@gmail.com jason@flawlessvapedistro.com
FEI Number: 3014131781
Country: United States
Issue Date: August 27, 2021
Issuing Office: Center for Tobacco Products
Product Type: Tobacco
Status: Open

Summary

Flawless Labs, Inc. d/b/a Flawless Vape Shop was cited for manufacturing and distributing e-liquid tobacco products without required premarket authorization, in violation of the Family Smoking Prevention and Tobacco Control Act and the Federal Food, Drug, and Cosmetic Act. The company's website offered e-liquids for sale in the United States, but these products—deemed tobacco products under FDA jurisdiction as of August 8, 2016—lacked the necessary premarket authorization orders required for "new tobacco products" not commercially marketed before February 15, 2007. The FDA determined that the products were adulterated and misbranded under applicable regulations.

Flawless Labs, Inc. d/b/a Flawless Vape Shop FDA Warning Letter, August 27, 2021